Detalhe da pesquisa
1.
Low Expression of the NRP1 Gene Is Associated with Shorter Overall Survival in Patients with Sonic Hedgehog and Group 3 Medulloblastoma.
Int J Mol Sci
; 24(14)2023 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37511358
2.
Oncogenic functions of ZEB1 in pediatric solid cancers: interplays with microRNAs and long noncoding RNAs.
Mol Cell Biochem
; 476(11): 4107-4116, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34292482
3.
Fingolimod (FTY720) reduces viability and survival and increases histone H3 acetylation in medulloblastoma cells.
Pediatr Hematol Oncol
; 37(2): 170-175, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826690
4.
Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists.
Childs Nerv Syst
; 32(1): 61-4, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26590027
5.
ZEB1 is a Subgroup-Specific Marker of Prognosis and Potential Drug Target in Medulloblastoma.
Neuromolecular Med
; 25(1): 64-74, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35716340
6.
Modulation of Viability, Proliferation, and Stemness by Rosmarinic Acid in Medulloblastoma Cells: Involvement of HDACs and EGFR.
Neuromolecular Med
; 25(4): 573-585, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37740824
7.
Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential.
Front Cell Dev Biol
; 8: 546, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32754588